Past events

Financial eventsTrade events
Interim Report 2, 2011
12 August 2011

Revenue down 1.4% (CER) and EBIT margin at 15.1% (CER) for the first 6 months

Interim Report 3, 2011
8 November 2011

Business improvements on track

Full Year Report 2011
9 February 2012

Business improvements remain on track

Annual General Meeting 2012
29 March 2012

Zurich, Switzerland

Dividend payment
5 April 2012

The AGM approved a dividend payment of CHF 0.15 per registered share.

Interim Report 1, 2012
27 April 2012

(01 - 26 April 2012 quiet period)

Media contact

N Weidmann

Nicolas Weidmann

Senior Vice President Communications

Nobel Biocare Management AG
P.O. Box
CH - 8058 Zurich-Airport
Switzerland

+41 43 211 42 80

+41 79 372 29 81

+41 43 211 42 42

Give us your feedback!

Summarize your comments
Email